| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1042385662 |
| P356 | DOI | 10.1186/1471-2164-15-199 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/1471-2164-15-199 |
| P932 | PMC publication ID | 4028079 |
| P698 | PubMed publication ID | 24628925 |
| P5875 | ResearchGate publication ID | 260839098 |
| P50 | author | Puneet Talwar | Q57336794 |
| Sandeep Grover | Q83774814 | ||
| P2093 | author name string | Ritushree Kukreti | |
| Rachna Agarwal | |||
| Suman Kushwaha | |||
| Meenal Gupta | |||
| Yumnam Silla | |||
| P2860 | cites work | Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases | Q39265227 |
| Cholesterol and amyloid-β: evidence for a cross-talk between astrocytes and neuronal cells | Q39560441 | ||
| mu-Opioid receptor cell surface expression is regulated by its direct interaction with Ribophorin I. | Q39872145 | ||
| Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. | Q40089983 | ||
| Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals | Q40206193 | ||
| A potential role for apoptosis in neurodegeneration and Alzheimer's disease | Q40437117 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| Role of Genes and Environments for Explaining Alzheimer Disease | Q22253029 | ||
| Islet cell autoantigen of 69 kDa is an arfaptin-related protein associated with the Golgi complex of insulinoma INS-1 cells | Q24299546 | ||
| Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors | Q24308715 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| The Universal Protein Resource (UniProt): an expanding universe of protein information | Q24538737 | ||
| Genenames.org: the HGNC resources in 2013 | Q24595108 | ||
| NCBI GEO: archive for functional genomics data sets--update | Q24595691 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| Genome-wide association study reveals genetic risk underlying Parkinson's disease | Q24646654 | ||
| A second generation human haplotype map of over 3.1 million SNPs | Q24651939 | ||
| GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers | Q24654145 | ||
| The human genome browser at UCSC | Q24672361 | ||
| Epidemiology of Alzheimer disease | Q26865371 | ||
| A comparative study of cancer proteins in the human protein-protein interaction network | Q27496590 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists | Q28131785 | ||
| Sys-BodyFluid: a systematical database for human body fluid proteome research | Q37202808 | ||
| Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. | Q37497056 | ||
| Amphiphysin I and regulation of synaptic vesicle endocytosis | Q37662707 | ||
| Evidence for impaired amyloid β clearance in Alzheimer's disease | Q37690374 | ||
| Network-based methods for human disease gene prediction | Q37901985 | ||
| Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease | Q38020089 | ||
| Computational tools for prioritizing candidate genes: boosting disease gene discovery | Q38023145 | ||
| Oligomeric amyloid-β peptide affects the expression of genes involved in steroid and lipid metabolism in primary neurons | Q38325429 | ||
| Age-related changes in gene expression are accelerated in Alzheimer's disease | Q38336477 | ||
| Walking the interactome for prioritization of candidate disease genes | Q39140568 | ||
| Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database | Q28280965 | ||
| The diabetes autoantigen ICA69 and its Caenorhabditis elegans homologue, ric-19, are conserved regulators of neuroendocrine secretion | Q28344845 | ||
| A new methodology to associate SNPs with human diseases according to their pathway related context | Q28477617 | ||
| Systems biology approach reveals genome to phenome correlation in type 2 diabetes | Q28484866 | ||
| Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice | Q28510217 | ||
| FAK+ and PYK2/CAKbeta, two related tyrosine kinases highly expressed in the central nervous system: similarities and differences in the expression pattern | Q28565223 | ||
| CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus | Q28572225 | ||
| Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells | Q28577298 | ||
| PICK1-ICA69 heteromeric BAR domain complex regulates synaptic targeting and surface expression of AMPA receptors | Q28578985 | ||
| Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression | Q28585864 | ||
| Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons | Q28592712 | ||
| Beyond differential expression: the quest for causal mutations and effector molecules | Q28727736 | ||
| Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease | Q28742427 | ||
| Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data | Q28943545 | ||
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database | Q29417106 | ||
| Human non-synonymous SNPs: server and survey | Q29547603 | ||
| Towards a knowledge-based Human Protein Atlas | Q29617987 | ||
| Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss | Q30420041 | ||
| Cytoskeletal pathologies of Alzheimer disease | Q30435267 | ||
| Meta-analysis of linkage studies for Alzheimer's disease--a web resource | Q30484112 | ||
| ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice | Q30497102 | ||
| Meta analysis of whole-genome linkage scans with data uncertainty: an application to Parkinson's disease | Q31117412 | ||
| Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. | Q31146509 | ||
| Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients | Q32062370 | ||
| Evaluation of clustering algorithms for protein-protein interaction networks | Q33262820 | ||
| Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. | Q33274604 | ||
| A computational analysis of protein-protein interaction networks in neurodegenerative diseases | Q33345563 | ||
| Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology | Q33345759 | ||
| Layered functional network analysis of gene expression in human heart failure | Q33486544 | ||
| GWAS meets microarray: are the results of genome-wide association studies and gene-expression profiling consistent? Prostate cancer as an example | Q33490113 | ||
| Gene prioritization in Type 2 Diabetes using domain interactions and network analysis | Q33528282 | ||
| ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. | Q33652534 | ||
| Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus | Q33679171 | ||
| Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains | Q33692288 | ||
| Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea | Q33759579 | ||
| Integrating the Alzheimer's disease proteome and transcriptome: a comprehensive network model of a complex disease | Q40963834 | ||
| Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins | Q40977784 | ||
| Limits of resolution of genetic linkage studies: implications for the positional cloning of human disease genes | Q41023780 | ||
| The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease | Q41215942 | ||
| Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome | Q41217019 | ||
| Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. | Q41437626 | ||
| How complete are current yeast and human protein-interaction networks? | Q41838577 | ||
| GeneVenn - A web application for comparing gene lists using Venn diagrams | Q41908722 | ||
| A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case | Q42567659 | ||
| Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk | Q42612701 | ||
| Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins | Q42668185 | ||
| A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. | Q43197086 | ||
| Differences in regional and subcellular localization of G(q/11) and RGS4 protein levels in Alzheimer's disease: correlation with muscarinic M1 receptor binding parameters | Q44209559 | ||
| S-linked protein homocysteinylation: identifying targets based on structural, physicochemical and protein-protein interactions of homocysteinylated proteins. | Q44778452 | ||
| Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death | Q45345438 | ||
| Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. | Q46843633 | ||
| Blood-based protein biomarkers for diagnosis of Alzheimer disease | Q47378944 | ||
| Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease | Q47596541 | ||
| Positional integratomic approach in identification of genomic candidate regions for Parkinson's disease | Q48135024 | ||
| Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. | Q48199367 | ||
| APID2NET: unified interactome graphic analyzer. | Q48392567 | ||
| Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions. | Q48787935 | ||
| Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. | Q48846656 | ||
| Differential regulation of proline-rich tyrosine kinase 2/cell adhesion kinase beta (PYK2/CAKbeta) and pp125(FAK) by glutamate and depolarization in rat hippocampus. | Q48860782 | ||
| The role of ABCA1 gene sequence variants on risk of Alzheimer's disease. | Q48965077 | ||
| Normalization of gene expression using SYBR green qPCR: a case for paraoxonase 1 and 2 in Alzheimer's disease brains. | Q50518641 | ||
| Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients. | Q51601187 | ||
| Computing topological parameters of biological networks. | Q51900389 | ||
| Characterization of the tyrosine kinases RAFTK/Pyk2 and FAK in nerve growth factor-induced neuronal differentiation. | Q52538801 | ||
| Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein. | Q53218418 | ||
| Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease. | Q53324676 | ||
| Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. | Q53333989 | ||
| Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease. | Q53334126 | ||
| Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease. | Q53896191 | ||
| Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease | Q56769920 | ||
| Genetic Analysis: Moving between Linkage and Association | Q57259233 | ||
| Risk of Cognitive Impairment or Dementia in Relatives of Patients With Parkinson Disease | Q57549862 | ||
| An unbiased evaluation of gene prioritization tools | Q60787745 | ||
| Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease | Q61046067 | ||
| Measurement of apolipoprotein E (apoE) in cerebrospinal fluid | Q73818777 | ||
| Microarray analysis in Alzheimer's disease and normal aging | Q80570828 | ||
| SCAN: SNP and copy number annotation | Q33779644 | ||
| Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE | Q33838241 | ||
| Prioritization of epilepsy associated candidate genes by convergent analysis | Q33842223 | ||
| Molecular mechanisms of neurodegeneration in Alzheimer's disease | Q33871297 | ||
| SPOT: a web-based tool for using biological databases to prioritize SNPs after a genome-wide association study | Q33957829 | ||
| clusterMaker: a multi-algorithm clustering plugin for Cytoscape | Q34070756 | ||
| The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE. | Q34123651 | ||
| Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype | Q34192190 | ||
| Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals | Q34305083 | ||
| A comprehensive network and pathway analysis of candidate genes in major depressive disorder | Q34333537 | ||
| Concerted perturbation observed in a hub network in Alzheimer's disease | Q34344867 | ||
| Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. | Q34385900 | ||
| ECRbase: database of evolutionary conserved regions, promoters, and transcription factor binding sites in vertebrate genomes | Q34580027 | ||
| Genetics of Alzheimer's disease: a centennial review | Q34656812 | ||
| A pilot study of gene/gene and gene/environment interactions in Alzheimer disease | Q34723301 | ||
| Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. | Q34807482 | ||
| Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death | Q34976924 | ||
| NCBI's Database of Genotypes and Phenotypes: dbGaP. | Q35057773 | ||
| Epidemiology of neurodegeneration | Q35062651 | ||
| Alzheimer's disease and Parkinson's disease | Q35097797 | ||
| A genome-wide association study of aging | Q35343147 | ||
| The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. | Q35558526 | ||
| Translating Mendelian and complex inheritance of Alzheimer's disease genes for predicting unique personal genome variants | Q35751270 | ||
| Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). | Q35781558 | ||
| Alzheimer disease susceptibility loci: evidence for a protein network under natural selection | Q35877845 | ||
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease | Q36183810 | ||
| Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models | Q36255584 | ||
| Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease | Q36283394 | ||
| Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. | Q36383616 | ||
| Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice | Q36822983 | ||
| Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration | Q36966655 | ||
| The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration | Q37017266 | ||
| Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. | Q37155515 | ||
| Genetic control of human brain transcript expression in Alzheimer disease | Q37156046 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 199 | |
| P577 | publication date | 2014-03-15 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease | |
| P478 | volume | 15 |
| Q41519395 | A Pilot Proteomic Analysis of Salivary Biomarkers in Autism Spectrum Disorder |
| Q37087410 | A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer's Disease |
| Q64068852 | ApoE4: an emerging therapeutic target for Alzheimer's disease |
| Q91268052 | Biomedical informatics applications for precision management of neurodegenerative diseases |
| Q38622890 | Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b |
| Q26750648 | Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models |
| Q37530095 | Differential burden of rare protein truncating variants in Alzheimer's disease patients compared to centenarians. |
| Q38583222 | Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective. |
| Q33734563 | Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology |
| Q101051196 | Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila |
| Q31030572 | Integrating Diverse Types of Genomic Data to Identify Genes that Underlie Adverse Pregnancy Phenotypes |
| Q55130393 | Integrative Analysis of Hippocampus Gene Expression Profiles Identifies Network Alterations in Aging and Alzheimer's Disease. |
| Q90499202 | Machine learning-based identification of genetic interactions from heterogeneous gene expression profiles |
| Q35648046 | Medical genetics and genomic medicine in India: current status and opportunities ahead |
| Q52600144 | Multifactorial Analysis of a Biomarker Pool for Alzheimer Disease Risk in a North Indian Population. |
| Q90681796 | NetControl4BioMed: a pipeline for biomedical data acquisition and analysis of network controllability |
| Q28552595 | Network Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the Disease |
| Q64113906 | Network approach identifies Pacer as an autophagy protein involved in ALS pathogenesis |
| Q28596503 | NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease |
| Q36434711 | PCOSKB: A KnowledgeBase on genes, diseases, ontology terms and biochemical pathways associated with PolyCystic Ovary Syndrome |
| Q35997979 | Presenilin 1 is necessary for neuronal, but not glial, EGFR expression and neuroprotection via γ-secretase-independent transcriptional mechanisms. |
| Q57479938 | Re-thinking Alzheimer's disease therapeutic targets using gene-based tests |
| Q61799924 | Regional protein expression in human Alzheimer's brain correlates with disease severity |
| Q38792491 | Retromer and Rab2-dependent trafficking mediate PS1 degradation by proteasomes in endocytic disturbance |
| Q26748815 | Review on Graph Clustering and Subgraph Similarity Based Analysis of Neurological Disorders |
| Q38662596 | Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease |
| Q38221025 | The emergence of proteome-wide technologies: systematic analysis of proteins comes of age. |
| Q35350853 | Transcriptomic analysis unveils correlations between regulative apoptotic caspases and genes of cholesterol homeostasis in human brain |
| Q58617327 | p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation |
Search more.